Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Ozon Pharmaceuticals explores opportunities to export products

3/4/25 OZPH

O'Key Group redomiciles to Russia

3/4/25 OKEY

Aeroflot reported for 2024 by IFRS

3/4/25 AFLT

VK reveals VK Tech metrics for the first time

3/4/25 VKCO

Segezha started placement of additional share issue

3/4/25 SGZH

Novoship reports for 2024 by RAS

3/4/25 NOMP

Number of orders of VseInstrumenty.ru in Q4 grew by 12%

3/4/25 VSEH

M.Video-Eldorado launched fast delivery via Yandex.Food and Deliveri

3/4/25 MVID

SPB Exchange summarized the results of trading in February

3/4/25 SPBE

MGKL's revenue for January-February grew 6.2 times

3/4/25 MGKL